Suppr超能文献

宏基因组下一代测序在诊断脊柱感染中的临床应用价值及其对临床结局的影响。

Clinical application value of metagenomic next-generation sequencing in the diagnosis of spinal infections and its impact on clinical outcomes.

机构信息

Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha, China.

National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.

出版信息

Front Cell Infect Microbiol. 2023 Feb 8;13:1076525. doi: 10.3389/fcimb.2023.1076525. eCollection 2023.

Abstract

This study aimed to evaluate the impact of precise treatment administered according to the results of metagenomic next-generation sequencing (mNGS) on the clinical outcomes of patients with spinal infections. In this multicenter retrospective study, the clinical data of 158 patients with spinal infections who were admitted to Xiangya Hospital Central South University, Xiangya Boai Rehabilitation Hospital, The First Hospital of Changsha, and Hunan Chest Hospital from 2017 to 2022 were reviewed. Among these 158 patients, 80 patients were treated with targeted antibiotics according to the mNGS results and were assigned to the targeted medicine (TM) group. The remaining 78 patients with negative mNGS results and those without mNGS and negative microbial culture results were treated with empirical antibiotics and assigned to the empirical drug (EM) group. The impact of targeted antibiotics based on the mNGS results on the clinical outcomes of patients with spinal infections in the two groups was analyzed. The positive rate of mNGS for diagnosing spinal infections was significantly higher than that of microbiological culture ( =83.92, <0.001), procalcitonin ( =44.34, <0.001), white blood cells ( =89.21, < 0.001), and IGRAs (Interferon-gamma Release Tests) ( = 41.50, < 0.001). After surgery, C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) showed a decreasing trend in the patients with spinal infections in both the TM and EM groups. The decrease in CRP was more obvious in the TM group than in the EM group at 7, 14 days, 3, and 6 months after surgery (<0.05). The decrease in ESR was also significantly obvious in the TM group compared with the EM group at 1 and 6 months after surgery (<0.05). The time taken for CRP and ESR to return to normal in the TM group was significantly shorter than that in the EM group (<0.05). There was no significant difference in the incidence of poor postoperative outcomes between the two groups. The positive rate of mNGS for the diagnosis of spinal infection is significantly higher than that of traditional detection methods. The use of targeted antibiotics based on mNGS results could enable patients with spinal infections to achieve a faster clinical cure.

摘要

这项研究旨在评估根据宏基因组下一代测序(mNGS)结果进行精准治疗对脊柱感染患者临床结局的影响。本研究为多中心回顾性研究,纳入 2017 年至 2022 年期间中南大学湘雅医院、湘雅博爱康复医院、长沙市第一医院和湖南省胸科医院收治的 158 例脊柱感染患者的临床资料。其中 80 例患者根据 mNGS 结果使用靶向抗生素治疗,归入靶向药物(TM)组,其余 78 例 mNGS 结果阴性和无 mNGS 及微生物培养结果的患者采用经验性抗生素治疗,归入经验性药物(EM)组。分析两组基于 mNGS 结果的靶向抗生素对脊柱感染患者临床结局的影响。mNGS 诊断脊柱感染的阳性率明显高于微生物培养( =83.92,<0.001)、降钙素原( =44.34,<0.001)、白细胞( =89.21,<0.001)和 IGRAs(干扰素-γ释放试验)( =41.50,<0.001)。脊柱感染患者手术后,TM 和 EM 组的 C 反应蛋白(CRP)和红细胞沉降率(ESR)均呈下降趋势,TM 组 CRP 术后 7、14 天、3、6 个月下降更明显(<0.05)。TM 组 ESR 术后 1、6 个月下降也明显优于 EM 组(<0.05)。TM 组 CRP 和 ESR 恢复正常的时间明显短于 EM 组(<0.05)。两组术后不良结局发生率无统计学差异。mNGS 诊断脊柱感染的阳性率明显高于传统检测方法。基于 mNGS 结果使用靶向抗生素可使脊柱感染患者更快获得临床治愈。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3499/9945583/cd9b78608a8c/fcimb-13-1076525-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验